Inventor · disambiguated record
Sotirios Tsimikas
Also filed as: TSIMIKAS SOTIRIOS
21 granted patents·9 pending applications·153 citations·filing 2000–2023
94Inventor score
Files withUNIV CALIFORNIA21INST NAT SANTE RECH MED3MALLAT ZIAD2TSIMIKAS SOTIRIOS2IONIS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
30 records- 0194US12209119B2Method of treating rheumatoid arthritis using antibodies to oxidized phospholipidsUNIV CALIFORNIA·Filed 2023·Granted Jan 28, 2025·1 cites·19 claims
- 0294US11008381B2Antibodies to oxidized phospholipidsUNIV CALIFORNIA·Filed 2018·Granted May 18, 2021·7 cites·15 claims
- 0394US6716410B1Reagents and methods for diagnosing, imaging and treating atherosclerotic diseaseUNIV CALIFORNIA·Filed 2000·Granted Apr 6, 2004·92 cites·19 claims
- 0493US11655288B2Antibodies to oxidized phospholipidsUNIV CALIFORNIA·Filed 2018·Granted May 23, 2023·5 cites·18 claims
- 0592US11008382B2Antibodies to oxidized phospholipidsUNIV CALIFORNIA·Filed 2018·Granted May 18, 2021·5 cites·15 claims
- 0690US7939287B2Methods of identifying a subject having or at risk of having or developing coronary artery diseaseUNIV CALIFORNIA·Filed 2009·Granted May 10, 2011·15 cites·16 claims
- 0786US11168148B2Antibodies to oxidation-specific epitopesUNIV CALIFORNIA·Filed 2017·Granted Nov 9, 2021·3 cites·18 claims
- 0880US7867476B2Method and materials for use in diagnosing viral myocarditisUNIV CALIFORNIA·Filed 2005·Granted Jan 11, 2011·2 cites·6 claims
- 0979US11530259B2Therapies and methods to treat TLR2-mediated diseases and disordersUNIV CALIFORNIA·Filed 2019·Granted Dec 20, 2022·2 cites·14 claims
- 1079US7556927B2Methods for diagnosing, imaging and treating atherosclerotic diseaseUNIV CALIFORNIA·Filed 2003·Granted Jul 7, 2009·5 cites·16 claims
- 1177US8361732B2Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventINST NAT SANTE RECH MED·Filed 2012·Granted Jan 29, 2013·2 cites·4 claims
- 1276US11897969B2Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injuryUNIV CALIFORNIA·Filed 2018·Granted Feb 13, 2024·1 cites·23 claims
- 1376US7575873B2Reagents for diagnosing, imaging and treating atherosclerotic diseaseUNIV CALIFORNIA·Filed 2003·Granted Aug 18, 2009·3 cites·8 claims
- 1474US12351649B2Antibodies to oxidation-specific epitopesUNIV CALIFORNIA·Filed 2021·Granted Jul 8, 2025·0 cites·13 claims
- 1574US9075050B2Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratiosUNIV CALIFORNIA·Filed 2013·Granted Jul 7, 2015·1 cites·5 claims
- 1673US8383355B2Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventINST NAT SANTE RECH MED·Filed 2009·Granted Feb 26, 2013·3 cites·15 claims
- 1769US2023357374A1Therapies and methods to treat tlr2-mediated diseases and disordersUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1868US9347959B2Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (TIA) and peripheral arterial disease (PAD)UNIV CALIFORNIA·Filed 2013·Granted May 24, 2016·1 cites·16 claims
- 1967US8163504B2Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventMALLAT ZIAD·Filed 2009·Granted Apr 24, 2012·2 cites·10 claims
- 2065US8129123B2Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratiosTSIMIKAS SOTIRIOS·Filed 2005·Granted Mar 6, 2012·2 cites·14 claims
- 2165US2012264146A1Combination of spla2 activity and lp(a) cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventMALLAT ZIAD·Filed 2009·Application pending·0 cites
- 2264US2015132771A1Combination of spla2 activity and lp(a) cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventINST NAT SANTE RECH MED·Filed 2014·Application pending·0 cites
- 2361US12441815B2Compositions and methods for diagnosis of cardiovascular diseaseUNIV CALIFORNIA·Filed 2019·Granted Oct 14, 2025·0 cites·16 claims
- 2461US8883428B2Methods to determine atherosclerosis regression, plaque stabilization and cardiovascular riskWITZTUM JOSEPH L·Filed 2010·Granted Nov 11, 2014·1 cites·9 claims
- 2560US2015376268A1Antibodies to oxidized phospholipidsUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 2656US2025321239A1High-throughput method for lp(a)-cholesterol quantitationUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 2755US2024033280A1Methods for reducing apociii expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2850US2012149596A1Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein b ratiosTSIMIKAS SOTIRIOS·Filed 2012·Application pending·0 cites
- 2946US2015056209A1Peptide mimotopes to oxidation specific epitopesUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 3041US2011097272A1Method and Materials for Use in Diagnosing Viral MyocarditisUNIV CALIFORNIA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sotirios Tsimikas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →